Kyoto Capital Partners
VC Fund
Kyoto, Japan
Kyoto Capital Partners is an investment company affiliated with the Bank of Kyoto.
- Total investments:
- 39
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Kyoto Capital Partners invests in
Stages Kyoto Capital Partners invests in
Countries Kyoto Capital Partners invests in
Round sizes
Round size
- Seed
- $102k–$2.9M
- Series A
- $955k–$29M
- Series B
- $1.2M–$16M
Investment Focus
Industry
- Health Care 9 (23%)
- Manufacturing 8 (21%)
- Medical 6 (15%)
- Consulting 5 (13%)
- Artificial Intelligence 5 (13%)
Stage
- Seed 10 (26%)
- Series A 9 (23%)
- Series B 9 (23%)
- Funding Round 3 (8%)
- Venture - Series Unknown 3 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Serendip Consulting refers to business portfolio optimization and provision of effective solutions.The Serendip Group operates not only strategic and financial consulting, but also a business company with a focus on manufacturing. Aiming for further growth of the entire group by restructuring the "business portfolio" based on the know-howof nurturing small and medium-sized businesses cultivated over 10 years since its foundation and investment experience, and "modernizing management" by dispatching professional managers You. | $15.5M / Post-IPO Equity / Jun 21, 2026 | |
|
Monozukuri Business Succession Holdings (JMS)
|
Monozukuri Business Succession Holdings is a specialized corporate investment subsidiary. The platform modernizes mid-sized manufacturing firms facing generational leadership transitions. Strategic institutional banking partnerships protect public shareholder equity from dilution. After acquisition, the firm installs professional management andautomated factory systems. All operational yields consolidate into the parent organization to drive long-term growth. | $12.5M / Venture - Series Unknown / Jun 01, 2026 | |
|
|
Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic. | $442.5M / May 28, 2026 | |
|
|
YStory is a digital health firm that uses AI and medical science to improve women's health during menopause. | Seed / Apr 27, 2026 | |
|
|
BALLAS provides corporate information, business content, procurement of construction materials, custom-made construction materials used at construction sites online, design, development, manufacturing, and sales of construction materials. | $13.2M / Series B / Apr 15, 2026 | |
|
|
RECOTECH is a ClimateTech firm that collects and shares data to maximize resource value throughout its life cycle, offering circular solutions to organizations and municipalities in Japan and beyond. | Series A / Feb 27, 2026 | |
|
|
CI Partners mission is to "eliminate the word 'disability' from this country," and with the message "Everyone is a star." | $2.6M / Series B / Dec 18, 2025 | |
|
|
LEP develops plants that glow without electricity. | $1M / Seed / Dec 16, 2025 | |
|
|
Aba develops products that reduce the burden of nursing care. Aba company has developed a device that can detect and record the excretion status of the care recipient, aiming to solve the mental and physical burden of the carer / care recipient by excretion sensing and pattern analysis. | Venture - Series Unknown / Dec 01, 2025 | |
|
SecureNavi
|
SecureNavi offers automation tools for the information security management system. It reduces conventional analogue operations using excel and word. For inquiries, telephone numbers and physical addresses are available on their website. | $7.8M / Series B / Nov 06, 2025 | |
| See all 39 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Kyoto Capital Partners invest in?
Kyoto Capital Partners invests primarily in Health Care, Manufacturing and Medical startups, most often at Seed and Series A stage. Most of the 39 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Kyoto Capital Partners's check size?
Kyoto Capital Partners typically joins rounds of $102k–$2.9M at Seed, $955k–$29M at Series A and $1.2M–$16M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kyoto Capital Partners participates in.
When did Kyoto Capital Partners last invest?
The most recent investment recorded for Kyoto Capital Partners closed in Jun 2026. Shizune tracks 39 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!